Myeloma Trial, Recruiting NCT06055894 Sponsor: Memorial Sloan Kettering Cancer Center Condition: Myeloma
Back to Myeloma

Myeloma Trial, Recruiting

NCT06055894
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have previously been diagnosed with MGUS or smoldering myeloma, with that diagnosis documented in a clinic note from their local oncologist within the past 6 months.
  • People aged 18 or older.
  • People who are willing to follow all study-related procedures.
  • People who are physically able to complete study tasks — such as meal preparation, sending stool samples, and filling out surveys — either on their own or with help from someone else.
  • People who are interested in learning to cook plant-based recipes.
  • People who have access to a smartphone or mobile device with a camera and can download the Keenoa app.
  • People who will be living within the United States for the full duration of the study.
  • People who speak English, or who have a family member or caregiver who speaks English and can help with surveys and the Keenoa app.

Who may not be able to join:

  • People taking supplements other than vitamin D, iron, vitamin B12, potassium, magnesium, calcium, or those taken for a specific medical reason — these cases must be reviewed by the lead researcher. People taking other supplements (such as curcumin, probiotics, or omega-3s) would need to stop taking them at least 2 weeks before joining the study.
  • People who already follow a whole foods plant-based diet — though ovo-lacto vegetarian diets or processed vegan diets are not excluded. A research dietitian would assess this during nutrition screening.
  • People with a legume allergy.
  • People with a severe allergy (such as anaphylactic reactions) to peanuts and/or tree nuts such as cashews.
  • People currently participating in other weight loss or dietary trials, or structured programs that require specific diets or supplements. People taking weight loss medications are not excluded.
  • People with a mental impairment that would prevent them from participating fully.
  • People currently enrolled in another investigational (experimental treatment) study.
  • People who are currently pregnant.
  • People taking full-dose blood-thinning (anticoagulation) medication.
  • People where the study investigator has concerns about whether the person could complete the study safely (confirm with trial site).
  • People who currently report heavy alcohol use, defined as more than 5 drinks per day or more than 15 drinks per week.
  • People who currently report use of illicit drugs — though inhaled marijuana, vaping, cigarette smoking, and medical marijuana are not excluded.
  • People who have needed antibiotics within 14 days before the study begins.
  • People who plan to travel during the study in a way that would prevent them from following the required diet.
  • People with a history of active inflammatory bowel disease, or who have had major gastrointestinal surgery (not including appendix or gallbladder removal) within 3 months before enrolling, or who have ever had their entire colon removed (total colectomy), or who have had bariatric (weight loss) surgery that changed the structure of the digestive tract — though purely restrictive procedures such as gastric banding are not excluded.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Urvi A Shah, MD, MS, Memorial Sloan Kettering Cancer Center

Phone: 646-608-3713

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 September 2023
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Relative abundance of stool butyrate producers at 2 weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov